Insider · CIK 0001321265

Hudson Leslie

Reports to the SEC for 4 companies · PORTLAND, OR

sec.gov

Transactions

Companies

Filings

CIK

0001321265

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2010-07-30	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−26K sh	$1.92	−$49.9K	384,559
2010-07-30	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−89K sh	$1.93	−$172K	410,541
2010-07-30	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−18.5K sh	$1.94	−$35.9K	499,559
2010-07-30	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−50K sh	$1.93	−$96.6K	518,045
2010-07-30	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	+183K sh	$1.09	+$200K	568,045
2010-07-30	SRPTSarepta Therapeutics, Inc. · Incentive Stock Option (right to buy)M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	−183K sh	—	—	0
2010-07-28	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−16.3K sh	$1.84	−$30.1K	408,396
2010-07-28	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−35.2K sh	$1.82	−$64.1K	432,845
2010-07-28	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−8,101 sh	$1.83	−$14.8K	424,744
2010-07-28	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	+183K sh	$1.09	+$200K	568,045
2010-07-28	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−70K sh	$1.81	−$127K	498,045
2010-07-28	SRPTSarepta Therapeutics, Inc. · Incentive Stock Option (right to buy)M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	−183K sh	—	—	183,486
2010-07-28	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−23.8K sh	$1.85	−$44.1K	384,559
2010-07-28	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−30K sh	$1.82	−$54.6K	468,045
2010-07-26	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−4,083 sh	$1.89	−$7,716.87	509,559
2010-07-26	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	+69K sh	$1.45	+$100K	453,524
2010-07-26	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	+60.1K sh	$1.45	+$87.2K	513,642
2010-07-26	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−82K sh	$1.90	−$156K	427,559
2010-07-26	SRPTSarepta Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	−60.1K sh	—	—	0
2010-07-26	SRPTSarepta Therapeutics, Inc. · Incentive Stock Option (right to buy)M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	−69K sh	—	—	0
2010-07-26	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−25K sh	$1.92	−$48K	384,559
2010-07-26	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−100 sh	$1.92	−$191.5	409,559
2010-07-26	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−17.9K sh	$1.91	−$34.2K	409,659
2010-07-23	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	+205K sh	$1.45	+$298K	589,959
2010-07-23	SRPTSarepta Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	−205K sh	—	—	60,118
2010-07-23	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−205K sh	$1.80	−$370K	384,559
2010-07-22	SRPTSarepta Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	−266K sh	—	—	265,518
2010-07-22	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	+266K sh	$1.45	+$385K	650,076
2010-07-22	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−53.8K sh	$1.79	−$96.3K	596,280
2010-07-22	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−200K sh	$1.80	−$359K	396,572
2010-07-22	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−12K sh	$1.81	−$21.7K	384,559
2010-07-16	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−9,200 sh	$1.86	−$17.1K	447,220
2010-07-16	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−28.2K sh	$1.88	−$53K	456,420
2010-07-16	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	+100K sh	$1.09	+$109K	484,587
2010-07-16	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−11.2K sh	$1.85	−$20.7K	431,359
2010-07-16	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−400 sh	$1.85	−$742	442,550
2010-07-16	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−46.8K sh	$1.89	−$88.5K	384,559
2010-07-16	SRPTSarepta Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	−100K sh	—	—	0
2010-07-16	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−4,070 sh	$1.91	−$7,773.7	442,950
2010-07-16	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−200 sh	$1.89	−$377	447,020
2010-07-09	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−37.5K sh	$1.61	−$60.4K	384,559
2010-07-09	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−2,500 sh	$1.63	−$4,075	432,059
2010-07-09	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−10K sh	$1.62	−$16.2K	422,059
2010-07-09	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	+50K sh	$1.09	+$54.5K	434,559
2010-07-09	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−7,700 sh	$1.58	−$12.2K	384,559
2010-07-09	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−136K sh	$1.57	−$214K	392,259
2010-07-09	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−4,000 sh	$1.55	−$6,200	528,559
2010-07-09	SRPTSarepta Therapeutics, Inc.S Sale	Former CEO, Former CEO	SSale	−2,000 sh	$1.56	−$3,120	532,559
2010-07-09	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	+150K sh	$1.09	+$164K	534,559
2010-07-09	SRPTSarepta Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Former CEO, Former CEO	MExercise/Conversion	−50K sh	—	—	100,028

Recent filings

Accepted (ET)
Aug 24
Hudson Leslie0000873303-10-000048
SEC(opens sec.gov)
Jul 294
Hudson Leslie0000873303-10-000046
SEC(opens sec.gov)
Jul 284
Hudson Leslie0000873303-10-000044
SEC(opens sec.gov)

Companies

Address

ONE SW COLUMBIA, SUITE 1105

PORTLAND, OR, 97258